A detailed history of Bank Of America Corp transactions in Innoviva, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,042,341 shares of INVA stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,042,341
Previous 914,665 13.96%
Holding current value
$21 Million
Previous $13.9 Million 22.63%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $1.84 Million - $2.09 Million
127,676 Added 13.96%
1,042,341 $17.1 Million
Q1 2024

May 15, 2024

BUY
$14.56 - $16.78 $1.71 Million - $1.97 Million
117,597 Added 14.75%
914,665 $13.9 Million
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $196,048 - $258,904
15,913 Added 2.04%
797,068 $12.8 Million
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $859,295 - $1.04 Million
75,443 Added 10.69%
781,155 $9.94 Million
Q1 2023

May 12, 2023

BUY
$10.73 - $13.6 $404,746 - $513,005
37,721 Added 5.65%
705,712 $7.94 Million
Q4 2022

Feb 10, 2023

SELL
$11.8 - $13.78 $97,668 - $114,057
-8,277 Reduced 1.22%
667,991 $8.85 Million
Q3 2022

Nov 14, 2022

SELL
$11.61 - $15.22 $14.4 Million - $18.9 Million
-1,238,955 Reduced 64.69%
676,268 $7.85 Million
Q2 2022

Aug 12, 2022

SELL
$14.32 - $19.88 $17.9 Million - $24.9 Million
-1,250,253 Reduced 39.5%
1,915,223 $28.3 Million
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $12.1 Million - $15.9 Million
786,670 Added 33.07%
3,165,476 $61.3 Million
Q4 2021

Feb 08, 2022

BUY
$15.91 - $18.72 $4.27 Million - $5.02 Million
268,358 Added 12.72%
2,378,806 $41 Million
Q3 2021

Nov 15, 2021

BUY
$13.06 - $17.24 $4.17 Million - $5.51 Million
319,661 Added 17.85%
2,110,448 $35.3 Million
Q2 2021

Sep 13, 2021

BUY
$11.45 - $13.96 $20.5 Million - $25 Million
1,790,787 New
1,790,787 $24 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.4B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.